RepliCel Life Sciences's total assets for Q3 2025 were C$9.79K, a decrease of -56.13% from the previous quarter. REPCF total liabilities were C$874.80K for the fiscal quarter, a -27.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.